Together, this suggests a potential broad involvement of PON1 in the various histological aspects of MASLD, reinforcing existing evidence connecting PON1 to liver steatosis, inflammation, fibrosis, and general MASLD [52,53,54]. Here, PON1 is linked to metabolic dysfunction-associated steatotic liver disease.